Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

Bibliographic Details
Main Authors: Cohen, Jeffrey A, Khatri, Bhupendra, Barkhof, Frederik, Comi, Giancarlo, Hartung, Hans-Peter, Montalban, Xavier, Pelletier, Jean, Stites, Tracy, Ritter, Shannon, von Rosenstiel, Philipp, Tomic, Davorka, Kappos, Ludwig
Format: Online
Language:English
Published: BMJ Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853559/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853559/

Similar Items